940941-43-5

Basic information

• Product Name: Nα-fluorenylmethyloxycarbonyl-L-lysine-tert-butyl ester
• Synonyms: Nα-fluorenylmethyloxycarbonyl-L-lysine-tert-butyl ester
• CAS NO: 940941-43-5
• Molecular Weight: 424.54
• Mol File: 940941-43-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Nα-fluorenylmethyloxycarbonyl-L-lysine-tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Nα-fluorenylmethyloxycarbonyl-L-lysine-tert-butyl ester(940941-43-5)
• EPA Substance Registry System: Nα-fluorenylmethyloxycarbonyl-L-lysine-tert-butyl ester(940941-43-5)

Safety Data

• Hazardous Substances Data: 940941-43-5(Hazardous Substances Data)

Upstream product

• 63628-63-7 Nε-benzyloxycarbonyl-L-lysine tert-butyl ester 
• 82911-69-1 N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide 
• 540-88-5 acetic acid tert-butyl ester 
• 105047-45-8 Fmoc-Lys-OH 

Downstream Products

• 105047-45-8 Fmoc-Lys-OH 
• 386213-32-7 (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-(2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetamido)pentanoic acid 

Relevant articles and documents

Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent

Radiotheranostics has attracted attention as a powerful strategy for treating cancer patients with precision medicine. We designed and synthesized a novel DOTA-based trifunctional agent, ADIBO-DOTADG-ALB (ADA), which allowed compounds with targeting ligands, radiometals, and an albumin binder to be readily prepared. ADA exhibited promising properties as a theranostic platform.

COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS

Compositions and methods for the treatment of fungal infections including compounds containing a pathogen pattern recognition receptor ligand and a β 1,3-glucan synthase inhibitor are disclosed. In particular, compounds containing a lipopeptide moiety and